Connecting you to content on EBSCOhost

Works by Boysen, Justin

Results: 6

1

Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.

Published in:

British Journal of Cancer, 2024, v. 131, n. 3, p. 589, doi. 10.1038/s41416-024-02752-1

By:

Sinha, Sutapa;
Guo, Ray;
Del Busso, Miles D.;
Han, Weiguo;
Boysen, Justin;
Wellik, Linda E.;
Ghosh, Asish K.;
Kay, Neil E.

Publication type:

Article

2

SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00484-6

By:

Maiti, Guru P.;
Sinha, Sutapa;
Mahmud, Hasan;
Boysen, Justin;
Mendez, Mariana T.;
Vesely, Sara K.;
Holter-Chakrabarty, Jennifer;
Kay, Neil E.;
Ghosh, Asish K.

Publication type:

Article

3

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.

Published in:

2021

By:

Sinha, Sutapa;
Secreto, Charla R.;
Boysen, Justin C.;
Lesnick, Connie;
Wang, Zhiquan;
Ding, Wei;
Call, Timothy G.;
Kenderian, Saad J.;
Parikh, Sameer A.;
Warner, Steven L.;
Bearss, David J.;
Ghosh, Asish K.;
Kay, Neil E.

Publication type:

Letter

4

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

Published in:

American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762

By:

Larsen, Jeremy T.;
Shanafelt, Tait D.;
Leis, Jose F.;
LaPlant, Betsy;
Call, Tim;
Pettinger, Adam;
Hanson, Curtis;
Erlichman, Charles;
Habermann, Thomas Matthew;
Reeder, Craig;
Nikcevich, Daniel;
Bowen, Deborah;
Conte, Michael;
Boysen, Justin;
Secreto, Charla;
Lesnick, Connie;
Tschumper, Renee;
Jelinek, Diane;
Kay, Neil E.;
Ding, Wei

Publication type:

Article

5

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Published in:

British Journal of Haematology, 2018, v. 183, n. 3, p. 421, doi. 10.1111/bjh.15545

By:

Hampel, Paul J.;
Larson, Melissa C.;
Kabat, Brian;
Call, Timothy G.;
Ding, Wei;
Kenderian, Saad S.;
Bowen, Deborah;
Boysen, Justin;
Schwager, Susan M.;
Leis, Jose F.;
Chanan‐Khan, Asher A.;
Muchtar, Eli;
Hanson, Curtis A.;
Slager, Susan L.;
Kay, Neil E.;
Chaffee, Kari G.;
Shanafelt, Tait D.;
Parikh, Sameer A.

Publication type:

Article

6

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

Published in:

British Journal of Haematology, 2009, v. 147, n. 4, p. 471, doi. 10.1111/j.1365-2141.2009.07868.x

By:

Ding, Wei;
Nowakowski, Grzegorz S.;
Knox, Traci R.;
Boysen, Justin C.;
Maas, Mary L.;
Schwager, Susan M.;
Wu, Wenting;
Wellik, Linda E.;
Dietz, Allan B.;
Ghosh, Asish K.;
Secreto, Charla R.;
Medina, Kay L.;
Shanafelt, Tait D.;
Zent, Clive S.;
Call, Timothy G.;
Kay, Neil E.

Publication type:

Article